Royal Bank of Canada’s Tenax Therapeutics TENX Stock Holding History

Royal Bank of Canada’s Portfolio TENX Stock Details TENX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$0	Buy	+4	New	+$54	﹤0.01%	7682
2024 Q3	–	Sell	-1	Closed	–	–	7425
2024 Q2	$0	Buy	+1	New	+$4	﹤0.01%	7522
2020 Q1	–	Hold	0	–	–	–	7014
2019 Q4	–	Hold	0	–	–	–	7110
2019 Q2	–	Hold	0	–	–	–	7172
2019 Q1	–	Hold	0	–	–	–	7095
2018 Q4	–	Hold	0	–	–	–	7105
2018 Q3	–	Hold	0	–	–	–	6945
2018 Q2	–	Hold	0	–	–	–	6763
2018 Q1	–	Hold	0	–	–	–	6777
2017 Q4	–	Hold	0	–	–	–	6875
2017 Q3	–	Hold	0	–	–	–	6974
2017 Q2	–	Hold	0	–	–	–	6757
2017 Q1	–	Hold	0	–	–	–	6811
2016 Q4	–	Hold	0	–	–	–	6566
2016 Q3	–	Hold	0	–	–	–	6304
2016 Q2	–	Hold	0	–	–	–	6267
2016 Q1	–	Hold	0	–	–	–	6233
2015 Q4	–	Hold	0	–	–	–	6379
2015 Q3	–	Hold	0	–	–	–	6387
2015 Q2	–	Hold	0	–	–	–	6323
2015 Q1	–	Hold	0	–	–	–	5996
2014 Q4	–	Hold	0	–	–	–	5982
2014 Q3	–	Hold	0	–	–	–	5753
2014 Q2	–	Hold	0	–	–	–	5666
2014 Q1	–	Hold	0	–	–	–	5620
2013 Q4	–	Hold	0	–	–	–	5713
2013 Q3	–	Hold	0	–	–	–	5973
2013 Q2	–	Hold	0	–	–	–	5631

Other funds holding TENX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Royal Bank of Canada's TENX Position: Q1 2026 in Review

Royal Bank of Canada opened a new position in Tenax Therapeutics (TENX) in Q1 2026: 4 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #7682 among its holdings. This is a return to the name: Royal Bank of Canada previously reported a position in TENX as recently as Q2 2024.

Royal Bank of Canada first reported a position in TENX in Q2 2024 and has held it in 2 quarters since. 80 funds tracked by Wall St. Rank hold TENX as of Q1 2026.

Royal Bank of Canada held 4 shares of Tenax Therapeutics worth $0 as of Q1 2026.
Tenax Therapeutics was a new Royal Bank of Canada position in Q1 2026.
Tenax Therapeutics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7682 holding.
Royal Bank of Canada first reported a position in Tenax Therapeutics in Q2 2024 and has held it in 2 quarters since.
80 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.